Docetaxel Aurobindo

Docetaxel Aurobindo is a chemotherapy medication used to treat various types of cancer. This intravenous drug is manufactured by Eugia Pharma (Malta) Ltd and is part of the EU pharmaceutical market.

Docetaxel is primarily used in the treatment of several types of cancer, including breast, lung, prostate, stomach, and head and neck cancers. It works by slowing or stopping the growth of cancer cells. The specific uses of Docetaxel can vary depending on the type and stage of cancer, as well as the patient's overall health.

Common effects of Docetaxel may include fatigue, nausea, vomiting, and hair loss. Some patients may also experience low blood cell counts, which can lead to increased risk of infections, bruising, or bleeding. It is important to discuss any side effects with a healthcare provider.

Docetaxel should be handled with care and administered by a healthcare professional. It is important to follow all safety guidelines and precautions provided by the manufacturer and healthcare provider. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment.

Docetaxel may interact with other medications, including those that affect the liver or bone marrow. It is important to inform your healthcare provider about all medications you are taking, including prescription, over-the-counter, and herbal products. Alcohol and certain foods may also interact with Docetaxel.